Back
BioCryst Pharmaceuticals Vs. Griffon Industry Stock Comparison
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
7.45
Seasonality Move:
10.41%
Buy
70
GFF
Griffon
Last Price:
77.38
Seasonality Move:
14.29%
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $7.65. The Score for BCRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Griffon (GFF)
is a Buy
Is Griffon a Buy, Sell or Hold?
- The current Griffon [GFF] share price is $80.52. The Score for GFF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- GFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $7.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 48.05 | Sell |
| Chaikin Money Flow: | -1199401 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.39 - 8.13) | Sell |
| Bollinger Bands (100): | (6.99 - 8.13) | Buy |
GFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.42 | Buy |
| Relative Strength Index (14 RSI): | 78.19 | Buy |
| Chaikin Money Flow: | 1692432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.12 - 70.34) | Buy |
| Bollinger Bands (100): | (62.68 - 70.2) | Buy |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.66 | Sell |
| 20-day SMA: | 7.86 | Sell |
| 50-day SMA: | 7.75 | Sell |
| 200-day SMA: | 6.5 | Buy |
| 8-day EMA: | 7.79 | Sell |
| 20-day EMA: | 7.79 | Sell |
| 50-day EMA: | 7.72 | Sell |
| 200-day EMA: | 7.06 | Buy |
GFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.94 | Buy |
| 20-day SMA: | 66.4 | Buy |
| 50-day SMA: | 66.92 | Buy |
| 200-day SMA: | 67.26 | Buy |
| 8-day EMA: | 70.29 | Buy |
| 20-day EMA: | 67.85 | Buy |
| 50-day EMA: | 67.02 | Buy |
| 200-day EMA: | 63.95 | Buy |
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.32 per share.
Griffon Earnings Growth & GFF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.76 per share.
BioCryst Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Griffon Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||